Cargando…
Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis
Autores principales: | Zhao, Chenyang, Cui, Zhao, Zhang, Yimiao, Wang, Fang, Wang, Xin, Cheng, Xuyang, Meng, Liqiang, Liu, Gang, Zhao, Minghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276299/ https://www.ncbi.nlm.nih.gov/pubmed/34935693 http://dx.doi.org/10.1097/CM9.0000000000001855 |
Ejemplares similares
-
Patients with primary focal segmental glomerulosclerosis with detectable urinary CD80 are more similar to patients with minimal change disease in clinicopathological features
por: Gong, Xiaojie, et al.
Publicado: (2023) -
Serum Metabolic Profiling in a Mouse Model of Adriamycin-Induced Focal Segmental Glomerulosclerosis
por: Lyu, Li, et al.
Publicado: (2018) -
Steroid-responsive polyradiculopathy in association with focal segmental glomerulosclerosis
por: Chapman, Andrew R., et al.
Publicado: (2013) -
Complement activation profile of patients with primary focal segmental glomerulosclerosis
por: Huang, Jing, et al.
Publicado: (2020) -
The Treatment of Minimal Change Nephropathy and Focal Segmental Glomerulosclerosis
por: Mason, P D
Publicado: (1997)